Orbital RadiothErapy, Sirolimus and Intravenous steroid for Primary Diplopia in Thyroid Eye Disease (RESIDE): a multi-center, double-masked, sham- and placebo-controlled randomized trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 13c157824050ccfc5b6eb486dc7fa579b9f8e1f2
First added on: Apr 22, 2026